Is KO stock currently overpriced, and is it possible that it could face a significant correction, perhaps by 25-30% or even ...

While the stock dropped nearly 57% from the peaks observed in early February 2025 following a report from a short-seller ...

Verve Therapeutics stock jumped after a report said pharmaceutical giant Eli Lilly is in advanced talks to buy the ...

Follow all the latest U.S. market action for Tuesday here as stocks sit just shy of record highs despite turmoil in the Middle East and the Federal Reserve begins its two-day policy meeting.

US stock futures fell with investors on edge as Israel and Iran continued to trade strikes against a backdrop of shifting US ...

US households are expected to scoop up a total of $425 billion in stocks this year, according to Goldman Sachs analysts.

Despite the Fed's reluctance to cut rates immediately, ample liquidity in the banking system supports further economic and ...

Investors and the wider public are looking for answers after Thursday’s crash of an Air India 787 jet. Both of the plane’s ...

Sarepta Therapeutics shares sank to their lowest level in nine years Monday after a second patient taking its Elevidys drug ...

That said, if you bought shares of Zoom a year ago, congratulations: You've more than doubled the performance of the S&P 500.

This setup could make it difficult for investors to find great deals. However, there's an opportunity hiding in plain sight.

The S&P 500 -- which is the stock market's main benchmark -- has historically averaged around 10% annual returns over the ...